HealthQuest Capital led a $142m round in OrganOx.

HealthQuest Capital, a growth equity, private equity firm investing in commercial-stage companies across the healthcare industry, led a $142m round in OrganOx, a UK-based medical technology company specializing in organ preservation and transplantation devices, with participation from BGF, Lauxera Capital Partners, Sofina, Soleus Capital, and Avidity Partners. “Organ disease and failure represent a large unmet need in healthcare, and we are excited to partner with HealthQuest Capital and the outstanding investor syndicate to work together to improve patient care and outcomes,” Oern R. Stuge, OrganOx Executive Chairman.